Which interventional strategy for diabetes mellitus patients? Understanding the challenges of PCI in everyday clinical practice

Sponsored by Alvimedica

Chairpersons: G. Sardella, M. Valgimigli
Panellists: R. Byrne, R. Romaguera
SHOW MORE

Summary

Consult this session to learn more about PCI performances with DES in diabetes mellitus patients, and discover all about the latest technological advancements provided by the innovative amphilimus-eluting polymer-free DES (Cre8 EVO).

Learning Objectives

  • To review PCI performances with DES in diabetes mellitus patients
  • To learn the latest technological advancements provided by the innovative amphilimus-eluting polymer-free DES (Cre8 EVO) in diabetes mellitus patients
  • To understand how to bridge the gap between PCI guidelines in diabetes mellitus patients and everyday clinical practice

Presentations available when logged in:

  • Session objectives
  • DES performances in diabetes mellitus patients: class effect?
  • Challenging DES efficacy in diabetics through DES innovation
  • Patient presentation
  • PCI or CABG in diabetic patients: from evidence to practice and back
  • Recorded cases from Milan, Italy
  • Session evaluation and key learnings